This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
RFA-AG-16-020: Impact of Aging on Currently Employed Animal Models of Disease and Chronic Conditions: Demonstration Projects (UH2/UH3) (co-funded by NIAID) – Receipt date Jan. 6, 2016.
Space Medical and Related Technologies Commercialization Assistance Program (SMARTCAP), issued by NSBRI Industry Forum - Receipt date Nov. 30, 2015
FDA Issues Final Animal Rule Guidance (PDF)—October 2015
NCATS' Pre-Clinical Programs Now Accepting Collaborative Proposals NCATS now is accepting proposals to collaborate with scientists from the Bridging Interventional Development Gaps and Therapeutics for Rare and Neglected Diseases programs.
NIAID Radiation and Nuclear Countermeasures Program (RNCP) gets approval for new Research Initiative Concepts at May 2015 Council Meeting.
FDA approves Neupogen® for treatment of patients with radiation-induced myelosuppression following a radiological/nuclear incident
NOT-OD-15-156: ASSIST Now an Option for Small Business Grant Applications. ASSIST is NIH's on-line system for the preparation, submission and tracking of grant applications through Grants.gov to NIH
PA-16-019: Innovation Corps (I-Corps™) at NIH Program for NIH and CDC Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grantees (Administrative Supplement)
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated November 10, 2015